Gracell Biotechnologies Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
13.43
|
|
Average Rating
|
4.71
|
|
# Strong Buys
|
5
|
|
# Buys
|
2
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-12-31
|
-0.13
|
0.00
|
0.13
|
100.00%
|
|
2022-09-30
|
-0.13
|
-0.07
|
0.06
|
46.15%
|
|
2022-06-30
|
-0.07
|
-0.30
|
-0.23
|
-328.57%
|
|
2022-03-31
|
-0.21
|
-0.07
|
0.14
|
66.67%
|
|
2021-12-31
|
-0.33
|
-0.30
|
0.03
|
9.09%
|
|
2021-09-30
|
-0.12
|
-0.30
|
-0.18
|
-150.00%
|
|
2021-06-30
|
-0.12
|
-0.20
|
-0.08
|
-66.67%
|
|
2021-03-31
|
-0.21
|
-0.25
|
-0.04
|
-19.05%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.44
|
|
2021-12-31
|
-1.05
|
|
2020-12-31
|
-0.24
|